ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.3K |
697K |
49 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
1.3K
|
697K
|
49
|
|
ASX - By Stock
|
NEU |
Re:
Competitors to Daybue
|
|
hottod
|
22 |
10K |
39 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
22
|
10K
|
39
|
|
ASX - By Stock
|
NEU |
The Value of Scarcity
|
|
hottod
|
4 |
3.3K |
153 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
4
|
3.3K
|
153
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.3K |
697K |
41 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
1.3K
|
697K
|
41
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.3K |
697K |
125 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
1.3K
|
697K
|
125
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
hottod
|
35 |
23K |
21 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
35
|
23K
|
21
|
|
ASX - By Stock
|
AVE |
Re:
Arthritis TPM Cannabis gel
|
|
hottod
|
46 |
11K |
13 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
46
|
11K
|
13
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PMS Drug Candidate Effective In Human Brain Cells
|
|
hottod
|
30 |
10K |
24 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
30
|
10K
|
24
|
|
ASX - By Stock
|
PYC |
Re:
Re: Ann: PMS Drug Candidate Effective
|
|
hottod
|
8 |
3.3K |
18 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
8
|
3.3K
|
18
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PMS Drug Candidate Effective In Human Brain Cells
|
|
hottod
|
30 |
10K |
7 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
30
|
10K
|
7
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
hottod
|
3.2K |
1.4M |
14 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
14
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PMS Drug Candidate Effective In Human Brain Cells
|
|
hottod
|
30 |
10K |
31 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
30
|
10K
|
31
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PMS Drug Candidate Effective In Human Brain Cells
|
|
hottod
|
30 |
10K |
25 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
30
|
10K
|
25
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
11K |
5.4M |
95 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
11K
|
5.4M
|
95
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
hottod
|
35 |
23K |
25 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
35
|
23K
|
25
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
11K |
5.4M |
31 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
11K
|
5.4M
|
31
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
11K |
5.4M |
95 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
11K
|
5.4M
|
95
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
hottod
|
188 |
79K |
23 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
188
|
79K
|
23
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
819 |
385K |
45 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
819
|
385K
|
45
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
hottod
|
188 |
79K |
63 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
188
|
79K
|
63
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
hottod
|
188 |
79K |
2 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
188
|
79K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
hottod
|
188 |
79K |
63 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
188
|
79K
|
63
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
hottod
|
188 |
79K |
54 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
188
|
79K
|
54
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Chair's Address and CEO Presentation
|
|
hottod
|
6 |
2.4K |
12 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
6
|
2.4K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
hottod
|
188 |
79K |
35 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
188
|
79K
|
35
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
hottod
|
188 |
79K |
62 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
188
|
79K
|
62
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
hottod
|
188 |
79K |
91 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
188
|
79K
|
91
|
|
ASX - By Stock
|
NEU |
Re:
Ann: AGM Chair Address & CEO Presentation
|
|
hottod
|
76 |
35K |
23 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
76
|
35K
|
23
|
|
ASX - By Stock
|
NEU |
Pipeline-in-a-drug
|
|
hottod
|
188 |
79K |
147 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
188
|
79K
|
147
|
|
ASX - By Stock
|
NEU |
Re:
Ann: AGM Chair Address & CEO Presentation
|
|
hottod
|
76 |
35K |
127 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
76
|
35K
|
127
|
|
ASX - By Stock
|
NEU |
Re:
The Field of Play for NEU through the eyes of Ken (AKA The Professor)
|
|
hottod
|
29 |
16K |
110 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
29
|
16K
|
110
|
|
ASX - By Stock
|
NEU |
Re:
The Field of Play for NEU through the eyes of Ken (AKA The Professor)
|
|
hottod
|
29 |
16K |
53 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
29
|
16K
|
53
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
hottod
|
231 |
126K |
35 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
231
|
126K
|
35
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
hottod
|
231 |
126K |
62 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
231
|
126K
|
62
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
hottod
|
231 |
126K |
14 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
231
|
126K
|
14
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024
|
|
hottod
|
61 |
21K |
13 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
61
|
21K
|
13
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Macquarie Australia Conference - Presentation
|
|
hottod
|
48 |
18K |
16 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
48
|
18K
|
16
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024
|
|
hottod
|
61 |
21K |
13 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
61
|
21K
|
13
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Macquarie Australia Conference - Presentation
|
|
hottod
|
48 |
18K |
20 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
48
|
18K
|
20
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Macquarie Australia Conference - Presentation
|
|
hottod
|
48 |
18K |
30 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
48
|
18K
|
30
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
819 |
385K |
31 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
819
|
385K
|
31
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
819 |
385K |
70 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
819
|
385K
|
70
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Completion of enrolment in Neuren's Angelman P2 trial
|
|
hottod
|
52 |
35K |
68 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
52
|
35K
|
68
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor presentation, 15 May 2024
|
|
hottod
|
34 |
19K |
23 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
34
|
19K
|
23
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor presentation, 15 May 2024
|
|
hottod
|
34 |
19K |
103 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
34
|
19K
|
103
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
11K |
5.4M |
43 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
11K
|
5.4M
|
43
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Successful GLP Tox Studies in Second Blinding Eye Disease
|
|
hottod
|
21 |
9.6K |
11 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
21
|
9.6K
|
11
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Successful GLP Tox Studies in Second Blinding Eye Disease
|
|
hottod
|
21 |
9.6K |
24 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
21
|
9.6K
|
24
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024
|
|
hottod
|
61 |
21K |
11 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
61
|
21K
|
11
|
|
ASX - By Stock
|
PNV |
Re:
Ann: First $A9M sales month and $A10M revenue month
|
|
hottod
|
207 |
69K |
1 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
207
|
69K
|
1
|
|